Attached files
| file | filename |
|---|---|
| EX-31.2 - Shengtai Pharmaceutical, Inc. | v211171_ex31-2.htm |
| EX-32.2 - Shengtai Pharmaceutical, Inc. | v211171_ex32-2.htm |
| EX-31.1 - Shengtai Pharmaceutical, Inc. | v211171_ex31-1.htm |
| 10-Q - Shengtai Pharmaceutical, Inc. | v211171_10q.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of Shengtai Pharmaceutical, Inc., the
“Company,” on Form 10-Q for the quarter ended December 31, 2010, as filed with
the Securities and Exchange Commission on the date hereof, the “Report,” I,
Qingtai Liu, Chairman and Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:
|
(1)
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
|
Date:
February 14, 2011
|
/s/
Qingtai
Liu
|
|
Qingtai
Liu
|
|
|
Title:
Chief Executive Officer
|
|
|
(Principal
Executive Officer)
|